Sh3rf2/POSHER Protein Promotes Cell Survival by Ring-mediated Proteasomal Degradation of the c-Jun N-terminal Kinase Scaffold POSH (Plenty of SH3s) Protein

被引:25
|
作者
Wilhelm, Michael [1 ,2 ]
Kukekov, Nickolay V. [3 ]
Schmit, Travis L. [1 ]
Biagas, Katherine V. [2 ]
Sproul, Andrew A. [3 ]
Gire, Stephen [2 ]
Maes, Margaret E. [1 ]
Xu, Zhiheng [3 ]
Greene, Lloyd A. [3 ]
机构
[1] Univ Wisconsin Madison, Dept Pediat, Madison, WI 53792 USA
[2] Columbia Univ Hlth Sci, Dept Pediat, New York, NY 10032 USA
[3] Columbia Univ Hlth Sci, Dept Pathol & Cell Biol, New York, NY 10032 USA
基金
美国国家卫生研究院;
关键词
JNK ACTIVATION; SYMPATHETIC NEURONS; PEPTIDE INHIBITOR; CEREBRAL-ISCHEMIA; APOPTOSIS; DEATH; PATHWAY; STRESS; IDENTIFICATION; EXCITOTOXICITY;
D O I
10.1074/jbc.M111.269431
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report that Sh3rf2, a homologue of the pro-apoptotic scaffold POSH (Plenty of SH3s), acts as an anti-apoptotic regulator for the c-Jun N-terminal kinase (JNK) pathway. siRNA-mediated knockdown of Sh3rf2 promotes apoptosis of neuronal PC12 cells, cultured cortical neurons, and C6 glioma cells. This death appears to result from activation of JNK signaling. Loss of Sh3rf2 triggers activation of JNK and its target c-Jun. Also, apoptosis promoted by Sh3rf2 knockdown is inhibited by dominant-negative c-Jun as well as by a JNK inhibitor. Investigation of the mechanism by which Sh3rf2 regulates cell survival implicates POSH, a scaffold required for activation of pro-apoptotic JNK/c-Jun signaling. In cells lacking POSH, Sh3rf2 knockdown is unable to activate JNK. We further find that Sh3rf2 binds POSH to reduce its levels by a mechanism that requires the RING domains of both proteins and that appears to involve proteasomal POSH degradation. Conversely, knockdown of Sh3rf2 promotes the stabilization of POSH protein and activation of JNK signaling. Finally, we show that endogenous Sh3rf2 protein rapidly decreases following several different apoptotic stimuli and that knockdown of Sh3rf2 activates the proapoptotic JNK pathway in neuronal cells. These findings support a model in which Sh3rf2 promotes proteasomal degradation of pro-apoptotic POSH in healthy cells and in which apoptotic stimuli lead to rapid loss of Sh3rf2 expression, and consequently to stabilization of POSH and JNK activation and cell death. On the basis of these observations, we propose the alter-native name POSHER (POSH-eliminating RING protein) for the Sh3rf2 protein.
引用
收藏
页码:2247 / 2256
页数:10
相关论文
共 37 条
  • [21] Stimulation of jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary αT3-1 cell line is mediated by protein kinase C, c-Src, and CDC42
    Levi, NL
    Hanoch, T
    Benard, O
    Rozenblat, M
    Harris, D
    Reiss, N
    Naor, Z
    Seger, R
    MOLECULAR ENDOCRINOLOGY, 1998, 12 (06) : 815 - 824
  • [22] Spleen tyrosine kinase promotes NLR family pyrin domain containing 3 inflammasome-mediated IL-1 secretion via c-Jun N-terminal kinase activation and cell apoptosis during diabetic nephropathy
    Qiao, Yingchun
    Tian, Xixi
    Men, Li
    Li, Shengyu
    Chen, Yufeng
    Xue, Meiting
    Hu, Yahui
    Zhou, Pengfei
    Long, Guangfeng
    Shi, Yue
    Liu, Ruiqing
    Liu, Yunde
    Qi, Zhi
    Cui, Yujie
    Shen, Yanna
    MOLECULAR MEDICINE REPORTS, 2018, 18 (02) : 1995 - 2008
  • [23] Activation of c-Jun NH2-terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3)-mediated cell growth
    Hassan, M
    Ghozlan, H
    Abdel-Kader, A
    VIROLOGY, 2005, 333 (02) : 324 - 336
  • [24] AM251 suppresses the viability of HepG2 cells through the AMPK (AMP-activated protein kinase)-JNK (c-Jun N-terminal kinase)-ATF3 (activating transcription factor 3) pathway
    Lee, Yun Mi
    Uhm, Kyung-Ok
    Lee, Eun Soo
    Kwon, Joseph
    Park, Sun Hwa
    Kim, Hyeon Soo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 370 (04) : 641 - 645
  • [25] Evidence that phosphatidylinositol 3-kinase- and mitogen-activated protein kinase kinase-4/c-Jun NH2-terminal kinase-dependent pathways cooperate to maintain lung cancer cell survival
    Lee, HY
    Srinivas, H
    Xia, DR
    Lu, YL
    Superty, R
    LaPushin, R
    Gomez-Manzano, C
    Gal, AM
    Walsh, GL
    Force, T
    Ueki, K
    Mills, GB
    Kurie, JM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (26) : 23630 - 23638
  • [26] A novel 52 kDa protein induces apoptosis and concurrently activates c-Jun N-terminal kinase 1 (JNK1) in mouse C3H10T1/2 fibroblasts
    Sun, LJ
    Liu, YL
    Frémont, M
    Schwarz, S
    Siegmann, M
    Matthies, R
    Jost, JP
    GENE, 1998, 208 (02) : 157 - 166
  • [27] Effect of Zishenpingchan granule prepared from Chinese medicinal substances on the c-Jun N-terminal protein kinase pathway in mice with Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    Ye Qing
    Yuan Xiaolei
    Zhou Jie
    Yuan Canxing
    Yang Xuming
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2017, 37 (02) : 244 - 251
  • [28] Effect of Zishenpingchan granule prepared from Chinese medicinal substances on the c-Jun N-terminal protein kinase pathway in mice with Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    Ye Qing
    Yuan Xiaolei
    Zhou Jie
    Yuan Canxing
    Yang Xuming
    Journal of Traditional Chinese Medicine, 2017, 37 (02) : 244 - 251
  • [29] Thromboxane A2 Receptor Inhibition Suppresses Multiple Myeloma Cell Proliferation by Inducing p38/c-Jun N-terminal Kinase (JNK) Mitogen-activated Protein Kinase ( MAPK)mediated G2/M Progression Delay and Cell Apoptosis
    Liu, Qian
    Tao, Bo
    Liu, Guizhu
    Chen, Guilin
    Zhu, Qian
    Yu, Ying
    Yu, Yu
    Xiong, Hong
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (09) : 4779 - 4792
  • [30] 1α,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes
    Johansen, C
    Kragballe, K
    Henningsen, J
    Westergaard, M
    Kristiansen, K
    Iversen, L
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (04) : 561 - 570